$3.940
-0.069 (-1.75%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
CNSP-Prognose durch Analyse ähnlicher Charts
Alphio's CNSP stock price prediction model matches the current CNS Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.97 (+0.88%). The 1-week path is $4.07 (+3.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich CNS Pharmaceuticals Inc-Aktien kaufen?
CNS Pharmaceuticals is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $3.94, with an RSI of 29.263 indicating oversold conditions. The company reported a net loss of approximately $4.937 million in Q1 2026, which is a 14.7% increase from the previous year's loss. Additionally, the stock has decreased by 39.29% over the past year, reflecting ongoing financial struggles and lack of revenue, which raises concerns about its long-term viability.
CNSP schloss am Friday bei $3.94, nachdem der Kurs -1.75% fallen
CNS Pharmaceuticals Inc (CNSP) last closed at $3.9400001, losing -1.75%. These facts feed the 1-day and 1-week CNSP price prediction above.
Prognose-Treiber
Die Prognose-Treiber von CNS Pharmaceuticals Inc (CNSP) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf CNSP am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für CNSP
Historically the probability of a positive November return for CNSP is 0.00%. January offers the highest probability of a positive month at 36.07%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für CNSP
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $0.63 | $0.75 | $0.86 | -80.99% |
| Dec 2026 | $0.77 | $0.91 | $0.98 | -76.97% |
Für 2026 wird für CNS Pharmaceuticals Inc (CNSP) eine Spanne von $0.63 bis $0.98 projiziert.
Monatsprognose 2026 für CNS Pharmaceuticals Inc
Im Nov 2026 wird für CNS Pharmaceuticals Inc ein Durchschnitt von $0.75 erwartet, mit einem Tief von $0.63 und einem Hoch von $0.86.
Im Dec 2026 wird für CNS Pharmaceuticals Inc ein Durchschnitt von $0.91 erwartet, mit einem Tief von $0.77 und einem Hoch von $0.98.
Ähnliche Artikel
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.